eli lilly ceo david ricks on positive alzheimer's drug trial data
Published 3 years ago • 5.2K plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
4:03
eli lilly ceo: alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
6:07
eli lilly ceo ricks on sales forecast, alzheimer's drug
-
4:14
eli lilly ceo david ricks on glp-1 and obesity drugs
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
27:41
losing greg: a dementia story
-
5:06
eli lilly's alzheimer's drug may cost about $39,000 for full use: neurologist | newsnation live
-
3:42
hat’s story: living with alzheimer’s disease
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
4:09
eli lilly alzheimer's drug does not slow memory loss | squawk box | cnbc
-
32:01
eli lilly ceo david ricks on coronavirus treatment developments (full stream 12/15)
-
1:47
promising data from eli lilly shows a significant slowdown in the pace of alzheimer's
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
6:48
eli lilly's alzheimer's drug slowed cognitive decline in phase 3 study
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline